Intimation about closure of trading window pursuant to SEBU (Prohibition of Insider Trading ) Regulation 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has informed the stock exchange that its trading window will be closed from Tuesday, 1st July 2025 until 48 hours after the company declares its financial results for the quarter ended 30th June 2025. The restriction applies to Directors, Key Managerial Personnel, Promoters, the Promoter Group, Designated Persons, and their immediate relatives, all of whom are barred from trading in the company's shares during this period. The board meeting date to consider the Q1 FY26 unaudited financial results will be announced separately. This is a standard compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015.
This is a routine regulatory announcement and does not carry any material business or price impact. It simply signals that the company's Q1 FY26 results are expected soon, which retail investors should watch for as the next key catalyst.